These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 5843584)
1. [Proketazine in the treatment of schizophrenia]. Jakubik A; Aleksandrowicz J Neurol Neurochir Psychiatr Pol; 1965; 15(4):639-45. PubMed ID: 5843584 [No Abstract] [Full Text] [Related]
2. [Proketazine in the treatment of psychotic syndromes]. KlosiĆska B; Wierzbicki T Psychiatr Pol; 1967; 1(1):69-71. PubMed ID: 5597274 [No Abstract] [Full Text] [Related]
3. Excessive mortality in schizophrenic patients on chronic phenothiazines treatment. Matsuki A; Oyama T; Izai S; Zsigmond EK Agressologie; 1972; 13(6):407-18. PubMed ID: 4652242 [No Abstract] [Full Text] [Related]
4. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients. Amin MM; Brahm E; Ban TA; Lehmann HE Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753 [No Abstract] [Full Text] [Related]
5. Piperacetazine in ambulatory chronic schizophrenic patients. Rada RT; Donlon PT Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665 [No Abstract] [Full Text] [Related]
6. [Thioproperazine: how dangerous is it?]. Vinar O Cesk Psychiatr; 1967 Aug; 63(4):274-6. PubMed ID: 4383546 [No Abstract] [Full Text] [Related]
7. A standard-controlled clinical study with propericiazine in schizophrenic patients. Ananth JV; Ban TA Psychopharmacol Bull; 1977 Jul; 13(3):19-20. PubMed ID: 18754 [No Abstract] [Full Text] [Related]
8. ["Depressive shift" in the course of treatment of schizophrenic psychosis with phenothiazines]. Bohacek N Neuropsihijatrija; 1967; 15(1):97-103. PubMed ID: 5191808 [No Abstract] [Full Text] [Related]
9. [Comparative study of 2 drugs and a placebo in chronic schizophrenia]. Tetreault L Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120 [No Abstract] [Full Text] [Related]
10. [Clinico-neuroleptic studies of the neuroleptic agent Propericiazine with special consideration of the neuroleptic threshold]. Haase HJ; Deinzer C; Rhinow E Med Welt; 1968 Jul; 27():1580-4. PubMed ID: 4388432 [No Abstract] [Full Text] [Related]
11. A controlled study of mesoridazine: an effective treatment for schizophrenia. McIndoo MV South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612 [No Abstract] [Full Text] [Related]
12. Clinical evaluation of butaperazine. Feldman PE Psychosomatics; 1967; 8(1):26-8. PubMed ID: 4382889 [No Abstract] [Full Text] [Related]
13. [Principles of a differentiated treatment of schizophrenia using psychotropic agents]. Awruzkij GJ Psychiatr Neurol Med Psychol (Leipz); 1966 Dec; 18(12):459-61. PubMed ID: 5983906 [No Abstract] [Full Text] [Related]
14. Letter: Sudden death while on phenothiazines. Bland RC Can Psychiatr Assoc J; 1975 Jun; 20(4):323-4. PubMed ID: 1182645 [No Abstract] [Full Text] [Related]
15. [Clinical remarks on the therapeutic activity of propericiazine]. Nava V G Psichiatr Neuropatol; 1967; 95(1):127-51. PubMed ID: 4386098 [No Abstract] [Full Text] [Related]
16. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia]. Matkowski K; Sep-Kowalikowa B Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095 [No Abstract] [Full Text] [Related]
17. [Clinical experiences with thiothixene (navane) in chronic schizophrenia]. Gann G Wien Med Wochenschr; 1968 Jan; 118(1):10-3. PubMed ID: 5668801 [No Abstract] [Full Text] [Related]
18. [Effects of TPN-12 Sandoz in schizophrenia]. Pogorzelski W; Rogiewicz A; Wojdyslawska I Psychiatr Pol; 1973; 7(1):65-8. PubMed ID: 4715834 [No Abstract] [Full Text] [Related]
19. [Liver enzyme activity in patients with schizophrenia in the course of treatment with majeptil]. Danilenko ET; Vlokh II Vrach Delo; 1976 Aug; (8):111-4. PubMed ID: 14445 [No Abstract] [Full Text] [Related]
20. An evaluation of the permanence of the "tardive dyskinesias". Paulson GW Dis Nerv Syst; 1968 Oct; 29(10):692-4. PubMed ID: 5717285 [No Abstract] [Full Text] [Related] [Next] [New Search]